SecBot SecBot
6-K ·Filed Apr 7, 2026

AKAN

AKANDA CORP.
NEUTRAL
Impact 4/10
Horizondays Processed6mo ago SEC0001213900-26-041103
Notable filing: 6-K
Actionable Insight • Neutral

Traders should monitor for follow-up filings regarding proxy solicitation progress and whether quorum is achieved at the April 27 meeting, which could impact governance decisions. Low market cap ($2M) increases sensitivity to potential changes in control or strategy.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
AKAN ▲ +289.63% at T+60d
NEUTRAL call +289.63% · α vs SPY +278.21% · entry $3.11 → $12.11
Entry = T+0 close
Apr 7, 2026
via day close
T+1d
-3.91%
call -3.91% · α -4.49%
$2.99
settled 7mo ago
T+5d
+6.50%
call +6.50% · α +2.96%
$3.31
settled 7mo ago
T+20d
+897.39%
call +897.39% · α +888.84%
$31.00
settled 6mo ago
T+60d
+289.63%
call +289.63% · α +278.21%
$12.11
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Akanda Corp. adjourned its special shareholder meeting on March 31, 2026, due to lack of quorum, and rescheduled it for April 27, 2026. The company will use the additional time to solicit shareholder proxies to meet the 10% voting threshold required for a quorum.

Key Facts

  • Special shareholder meeting convened on March 31, 2026, was adjourned due to absence of quorum.
  • Quorum requires at least two shareholders representing not less than 10% of outstanding voting shares.
  • Meeting rescheduled for April 27, 2026, at the same location and time.
  • Record date for voting remains February 26, 2026; previously submitted proxies remain valid unless revoked.
  • Company is actively soliciting shareholder participation to ensure quorum at the reconvened meeting.

Financial Impact

No immediate financial impact disclosed; adjournment delays potential shareholder decisions but does not alter financial position.

quorumshareholder participationgovernance

Risk Factors

  • Failure to achieve quorum at the reconvened meeting could delay or prevent critical corporate actions.
  • Low shareholder engagement may signal broader governance or investor confidence issues.

Market Snapshot

Exchange
Nasdaq
Sector
Medicinal Chemicals & Botanical Products

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001213900-26-041103
Document: ea028535501ex99-1.htm0001213900-26-041103
Document: 0001213900-26-041103-index-headers.html0001213900-26-041103
Document: 0001213900-26-041103-index.html0001213900-26-041103
Document: 0001213900-26-041103.txt0001213900-26-041103
15 reports for AKAN
Performance horizon
100% Hit rate @ T+20 6 of 6 directional calls Went positive at some point 9 of 9 best @ T+60▲ +82.98%May 22, 2026
Filters
Rows
Reports for AKAN — sortable, filterable
TypeNow
Oct 19, 2026
7d ago
F-1/A
BEARISH ★ 7/10
$1.12awaiting T+20—$1.05 (+6.25%)
Oct 1, 2026
25d ago
F-1
BEARISH ★ 7/10
$1.98awaiting T+20—$1.05 (+46.97%)
Sep 30, 2026
26d ago
6-K
BEARISH ★ 7/10
$2.21awaiting T+20—$1.05 (+52.49%)
Sep 25, 2026
4w ago
6-K
BEARISH ★ 7/10
$2.83 $1.05▲ +62.83%▲ +62.80%$1.05 (+62.83%)
Sep 4, 2026
7w ago
6-K
NEUTRAL ★ 4/10
$3.35 $1.91▼ −42.99%▼ −43.59%$1.05 (−68.66%)
Aug 17, 2026
10w ago
6-K
BEARISH ★ 7/10
$4.86 $2.72▲ +44.14%▲ +43.15%$1.05 (+78.40%)
Jun 18, 2026
18w ago
6-K
BEARISH ★ 8/10
$15.07 $7.96▲ +47.18%▲ +47.70%$1.05 (+93.03%)
Jun 12, 2026
19w ago
6-K
MIXED ★ 6/10
$18.54 $9.48▼ −48.87%▼ −50.23%$1.05 (−94.34%)
Jun 9, 2026
19w ago
20-F
BEARISH ★ 8/10
$13.81 $10.05▲ +27.23%▲ +30.85%$1.05 (+92.40%)
May 22, 2026
22w ago
6-K
BEARISH ★ 7/10
$23.86 $15.70▲ +34.22%▲ +32.27%$1.05 (+95.60%)
Showing 10 of 15

US Market Status

Market Closed — Opens Tue (15h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 7, 2026